Drug Profile
Calcipotriol - Polichem
Alternative Names: P 3073Latest Information Update: 05 Nov 2023
Price :
$50
*
At a glance
- Originator Polichem
- Class Antipsoriatics; Cyclohexanes; Cyclopropanes; Dihydroxycholecalciferols; Indenes; Vitamin D analogues
- Mechanism of Action Calcitriol receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Psoriasis
Most Recent Events
- 24 Sep 2020 Discontinued - Phase-II for Psoriasis in Italy (Topical) (Almirall pipeline, September 2020)
- 24 Sep 2020 Discontinued - Phase-III for Psoriasis in Latvia, Germany, Czech Republic, Poland, Bulgaria, Greece and Russia (Topical) (Almirall pipeline, September 2020)
- 10 Jan 2018 Polichem withdraws a phase III trial in Psoriasis in USA (NCT03079973)